Surface glycopolymers are crucial for in vitro anti-wall teichoic acid IgG-mediated complement activation and opsonophagocytosis of Staphylococcus aureus

Infection and Immunity

Volumn 83, Issue 11, 2015, Pages 4247-4255

  Lee, Jong Ho ^a   Kim, Na Hyang ^a   Winstel, Volker ^b   Kurokaw, Kenji ^a,c   Larsen, Jesper ^d   An, Jang Hyun ^a   Khan, Adnan ^a   Seong, Min Young ^a   Lee, Min Ja ^a   Andersen, Paal Skytt ^d   Peschel, Andreas ^b   Lee, Bok Luel ^a  

^a Pusan National University   (South Korea)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CAPSULAR POLYSACCHARIDE; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G; N ACETYLGALACTOSAMINE; TEICHOIC ACID; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; GLYCOSYLTRANSFERASE;

ADULT; ARTICLE; BACTERIAL CELL; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COMPLEMENT ACTIVATION; GLYCOSYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OPSONOPHAGOCYTOSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS PHAGE; CELL WALL; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

BACTERIAL PROTEINS; CELL WALL; COMPLEMENT ACTIVATION; COMPLEMENT C3; GLYCOSYLTRANSFERASES; HUMANS; IMMUNOGLOBULIN G; PHAGOCYTOSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS;

EID: 84947599635     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00767-15     Document Type: Article

References (49)

1. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339:520-532. http://dx.doi.org/10.1056/NEJM199808203390806.
2. DeLeo FR, Diep BA, Otto M. 2009. Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am 23:17-34. http://dx.doi.org/10.1016/j.idc.2008.10.003.
3. Parker D, Prince A. 2012. Immunopathogenesis of Staphylococcus aureus pulmonary infection. Semin Immunopathol 34:281-297. http://dx.doi.org/10.1007/s00281-011-0291-7.
4. Fowler VG, Jr, Proctor RA. 2014. Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect 20(Suppl 5):S66-S75. http://dx.doi.org/10.1111/1469-0691.12570.
5. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771. http://dx.doi.org/10.1001/jama.298.15.1763.
6. Fujita T. 2002. Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol 2:346-353. http://dx.doi.org/10.1038/nri800.
7. Ip WK, Takahashi K, Ezekowitz RA, Stuart LM. 2009. Mannose-binding lectin and innate immunity. Immunol Rev 230:9-21. http://dx.doi.org/10.1111/j.1600-065X.2009.00789.x.
8. Weidenmaier C, Peschel A. 2008. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev 6:276-287. http://dx.doi.org/10.1038/nrmicro1861.
9. Brown S, Santa Maria JP, Jr, Walker S. 2013. Wall teichoic acids of gram-positive bacteria. Annu Rev Microbiol 67:313-336. http://dx.doi.org/10.1146/annurev-micro-092412-155620.
10. Swoboda JG, Campbell J, Meredith TC, Walker S. 2010. Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem 11:35-45. http://dx.doi.org/10.1002/cbic.200900557.
11. Xia G, Kohler T, Peschel A. 2010. The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. Int J Med Microbiol 300:148-154. http://dx.doi.org/10.1016/j.ijmm.2009.10.001.
12. Winstel V, Liang C, Sanchez-Carballo P, Steglich M, Munar M, Broker BM, Penades JR, Nubel U, Holst O, Dandekar T, Peschel A, Xia G.2013. Wall teichoic acid structure governs horizontal gene transfer between major bacterial pathogens. Nat Commun 4:2345. http://dx.doi.org/10.1038/ncomms3345.
13. Xia G, Maier L, Sanchez-Carballo P, Li M, Otto M, Holst O, Peschel A. 2010. Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM. J Biol Chem 285:13405-13415. http://dx.doi.org/10.1074/jbc.M109.096172.
14. Brown S, Xia G, Luhachack LG, Campbell J, Meredith TC, Chen C, Winstel V, Gekeler C, Irazoqui JE, Peschel A, Walker S. 2012. Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc Natl Acad Sci U S A 109:18909-18914. http://dx.doi.org/10.1073/pnas.1209126109.
15. Winstel V, Xia G, Peschel A. 2014. Pathways and roles of wall teichoic acid glycosylation in Staphylococcus aureus. Int J Med Microbiol 304:215-221. http://dx.doi.org/10.1016/j.ijmm.2013.10.009.
16. Ricklin D, Hajishengallis G, Yang K, Lambris JD. 2010. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11: 785-797. http://dx.doi.org/10.1038/ni.1923.
17. Daha NA, Banda NK, Roos A, Beurskens FJ, Bakker JM, Daha MR, Trouw LA. 2011. Complement activation by (auto-) antibodies. Mol Immunol 48:1656-1665. http://dx.doi.org/10.1016/j.molimm.2011.04.024.
18. Weis WI, Drickamer K. 1996. Structural basis of lectin-carbohydrate recognition. Annu Rev Biochem 65:441-473. http://dx.doi.org/10.1146/annurev.bi.65.070196.002301.
19. Park KH, Kurokawa K, Zheng L, Jung DJ, Tateishi K, Jin JO, Ha NC, Kang HJ, Matsushita M, Kwak JY, Takahashi K, Lee BL. 2010. Human serum mannose-binding lectin senses wall teichoic acid glycopolymer of Staphylococcus aureus, which is restricted in infancy. J Biol Chem 285: 27167-27175. http://dx.doi.org/10.1074/jbc.M110.141309.
20. Jung DJ, An JH, Kurokawa K, Jung YC, Kim MJ, Aoyagi Y, Matsushita M, Takahashi S, Lee HS, Takahashi K, Lee BL. 2012. Specific serum Ig recognizing staphylococcal wall teichoic acid induces complementmediated opsonophagocytosis against Staphylococcus aureus. J Immunol 189:4951-4959. http://dx.doi.org/10.4049/jimmunol.1201294.
21. Kurokawa K, Jung DJ, An JH, Fuchs K, Jeon YJ, Kim NH, Li X, Tateishi K, Park JA, Xia G, Matsushita M, Takahashi K, Park HJ, Peschel A, Lee BL. 2013. Glycoepitopes of staphylococcal wall teichoic acid govern complement-mediated opsonophagocytosis via human serum antibody and mannose-bindinglectin.JBiolChem 288:30956-30968.http://dx.doi.org/10.1074/jbc.M113.509893.
22. Takahashi K, Kurokawa K, Moyo P, Jung DJ, An JH, Chigweshe L, Paul E, Lee BL. 2013. Intradermal immunization with wall teichoic acid (WTA)elicitsandaugmentsananti-WTAIgGresponsethatprotectsmice from methicillin-resistant Staphylococcus aureus infection independent of mannose-binding lectin status. PLoS One 8:e69739. http://dx.doi.org/10.1371/journal.pone.0069739.
23. Tuchscherr L, Loffler B, Buzzola FR, Sordelli DO. 2010. Staphylococcus aureus adaptation to the host and persistence: role of loss of capsular polysaccharide expression. Future Microbiol 5:1823-1832. http://dx.doi.org/10.2217/fmb.10.147.
24. O'Riordan K, Lee JC. 2004. Staphylococcus aureus capsular polysaccharides.ClinMicrobiolRev 17:218-234.http://dx.doi.org/10.1128/CMR.17.1.218-234.2004.
25. Thakker M, Park JS, Carey V, Lee JC. 1998. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterialvirulenceinamurinebacteremiamodel.InfectImmun 66:5183-5189.
26. Cunnion KM, Lee JC, Frank MM. 2001. Capsule production and growth phaseinfluencebindingofcomplementto Staphylococcus aureus. InfectImmun 69:6796-6803. http://dx.doi.org/10.1128/IAI.69.11.6796-6803.2001.
27. Matsushita M, Endo Y, Fujita T. 2000. Cutting edge: complementactivating complex of ficolin and mannose-binding lectin-associated serine protease. J Immunol 164:2281-2284. http://dx.doi.org/10.4049/jimmunol.164.5.2281.
28. Shiratsuchi A, Shimizu K, Watanabe I, Hashimoto Y, Kurokawa K, Razanajatovo IM, Park KH, Park HK, Lee BL, Sekimizu K, Nakanishi Y.2010.Auxiliaryrolefor D-alanylatedwallteichoicacidinToll-likereceptor 2-mediated survival of Staphylococcus aureus in macrophages. Immunology 129:268-277. http://dx.doi.org/10.1111/j.1365-2567.2009.03168.x.
29. Pantucek R, Doskar J, Ruzickova V, Kasparek P, Oracova E, Kvardova V, Rosypal S. 2004. Identification of bacteriophage types and their carriage in Staphylococcus aureus. Arch Virol 149:1689-1703. http://dx.doi.org/10.1007/s00705-004-0335-6.
30. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403-410. http://dx.doi.org/10.1016/S0022-2836(05)80360-2.
31. Portoles M, Kiser KB, Bhasin N, Chan KH, Lee JC. 2001. Staphylococcus aureus Cap5O has UDP-ManNAc dehydrogenase activity and is essential for capsule expression. Infect Immun 69:917-923. http://dx.doi.org/10.1128/IAI.69.2.917-923.2001.
32. Endl J, Seidl PH, Fiedler F, Schleifer KH. 1984. Determination of cell wall teichoic acid structure of staphylococci by rapid chemical and serologicalscreeningmethods.ArchMicrobiol 137:272-280.http://dx.doi.org/10.1007/BF00414557.
33. Xia G, Corrigan RM, Winstel V, Goerke C, Grundling A, Peschel A.2011. Wall teichoic acid-dependent adsorption of staphylococcal siphovirus and myovirus. J Bacteriol 193:4006-4009. http://dx.doi.org/10.1128/JB.01412-10.
34. Winstel V, Sanchez-Carballo P, Holst O, Xia G, Peschel A. 2014. Biosynthesis of the unique wall teichoic acid of Staphylococcus aureus lineage ST395. mBio 5(2):e00869-14. http://dx.doi.org/10.1128/mBio.00869-14.
35. Juergens WG, Sanderson AR, Strominger JL. 1963. Chemical basis for an immunological specificity of a strain of Staphylococcus aureus. J Exp Med 117:925-935. http://dx.doi.org/10.1084/jem.117.6.925.
36. Colque-Navarro P, Jacobsson G, Andersson R, Flock JI, Mollby R. 2010. Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population. Clin Vaccine Immunol 17:1117-1123. http://dx.doi.org/10.1128/CVI.00506-09.
37. Anderson AS, Miller AA, Donald RG, Scully IL, Nanra JS, Cooper D, Jansen KU. 2012. Development of a multicomponent Staphylococcus aureusvaccinedesignedtocountermultiplebacterialvirulencefactors.Hum Vaccin Immunother 8:1585-1594. http://dx.doi.org/10.4161/hv.21872.
38. Holtfreter S, Kolata J, Broker BM. 2010. Towards the immune proteome of Staphylococcus aureus-the anti-S. aureus antibody response. Int J Med Microbiol 300:176-192. http://dx.doi.org/10.1016/j.ijmm.2009.10.002.
39. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J 12:3967-3975.
40. Oku Y, Kurokawa K, Matsuo M, Yamada S, Lee BL, Sekimizu K. 2009. Pleiotropic roles of poly-glycerolphosphate synthase of lipoteichoic acid in the growth of Staphylococcus aureus cells. J Bacteriol 191:141-151. http://dx.doi.org/10.1128/JB.01221-08.
41. Winstel V, Kuhner P, Salomon F, Larsen J, Skov R, Hoffmann W, Peschel A, Weidenmaier C. 2015. Wall teichoic acid glycosylation governs Staphylococcus aureusnasalcolonization.mBio 6(4):e00632-15.http://dx.doi.org/10.1128/mBio.00632-15.
42. Murakami K, Tomasz A. 1989. Involvement of multiple genetic determinants in high-level methicillin resistance in Staphylococcus aureus. J Bacteriol 171:874-879.
43. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K. 2002. Genome and virulence determinants of high virulence community-acquiredMRSA.Lancet 359:1819-1827.http://dx.doi.org/10.1016/S0140-6736(02)08713-5.
44. Karakawa WW, Vann WF. 1982. Capsular polysaccharides of Staphylococcus aureus, p 285-293. In Robbins JB, Hill JC, Sadoff JC (ed), Seminars in infectious diseases, vol IV. Bacterial vaccines. Thieme-Stratton Inc., New York, NY.
45. Scott AC. 1969. A capsulate Staphylococcus aureus. J Med Microbiol 2:253-260. http://dx.doi.org/10.1099/00222615-2-3-253.
46. Fournier JM, Vann WF, Karakawa WW. 1984. Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide. Infect Immun 45:87-93.
47. Hunt GA, Moses AJ. 1958. Acute infection of mice with Smith strain of Staphylococcus aureus. Science 128:1574-1575. http://dx.doi.org/10.1126/science.128.3338.1574.
48. Karakawa WW, Sutton A, Schneerson R, Karpas A, Vann WF. 1988. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun 56:1090-1095.
49. Jones D, Deibel RH, Niven CF, Jr. 1963. Identity of Staphylococcus epidermidis. J Bacteriol 85:62-67.